Skip to main content

Table 1 Demographic, laboratory and clinical characteristics

From: Immunological effects of glutamine supplementation in polytrauma patients in intensive care unit

 

Control EN

Group 1

n.15

GLN-enriched EN

Group 2

n.15

p value

Age (y)

53.5±11.4

54.0±11.7

0.57

Weight (kg)

76±16.4

74.53±16.9

0.48

Height (cm)

165±9.2

165±7.5

0.22

BMI (kg/cm2)

28.7±8.1

29.1±8.9

0.19

Sex (M/F)

8/7

10/5

0,17

Albumin (g/dl)

2.5±0.9

2.8±0.6

0.82

Proteins (g/dl)

5.3±0,9

6.2±0.8

0.91

Plasmatic urea level (mmol/litre)

41±9.2

45±8.1

0.46

GCS score

11±2

12±3

0.40

ISS score

27.5±10.1

40.9±19.8

0.09

SAPS score

45.4±12.1

45.8±9.8

0.9

APACHES II score

23.6±3.6

21.4±6.3

0.76

ICU length of stay (days)

25±5

20±7

0.39

ICU mortality, n (%)

6 (40)

5 (33.3)

0.4

MV time (d)

9.26±1.3

9±1.4

0.31